Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

未开盘 12-19 16:00:00 EST

4.26

-0.18

-4.05%

盘后4.39

+0.13+3.05%

19:59 EST

最高4.53	最低4.25	成交量5,501万
今开4.51	昨收4.44	日振幅6.31%
总市值22.15亿	流通市值17.68亿	总股本5.20亿
成交额2.39亿	换手率13.26%	流通股本4.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":4.26,"timestamp":1766178000000,"preClose":4.44,"halted":0,"volume":55008432,"hourTrading":{"tag":"盘后","latestPrice":4.39,"preClose":4.26,"latestTime":"19:59 EST","volume":5366208,"amount":22921928.6096,"timestamp":1766192373974},"delay":0,"floatShares":415000000,"shares":519837585,"eps":-1.783934,"marketStatus":"未开盘","change":-0.18,"latestTime":"12-19 16:00:00 EST","open":4.51,"high":4.53,"low":4.25,"amount":238650044.6130912,"amplitude":0.063063,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.783934,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":0,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":4.44,"preHourTrading":{"tag":"盘前","latestPrice":4.5,"preClose":4.44,"latestTime":"09:29 EST","volume":340557,"amount":1555237.6580790002,"timestamp":1766154599999},"postHourTrading":{"tag":"盘后","latestPrice":4.39,"preClose":4.26,"latestTime":"19:59 EST","volume":5366208,"amount":22921928.6096,"timestamp":1766192373974},"volumeRatio":1.8805571694734446,"optionData":{"bulkOrders":[{"symbol":"RXRX","call":false,"expireDate":1768539600000,"strike":"4.5","timestamp":1766158648858,"price":0.45,"volume":2000,"amount":90000,"type":"-"}]},"impliedVol":0.8394,"impliedVolPercentile":0.116},"requestUrl":"/m/hq/s/RXRX","defaultTab":"news","newsList":[{"id":"2592922274","title":"小摩上调Recursion(RXRX.US)评级至“增持”，核心管线REC-4881有望成为畅销药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2592922274","media":"智通财经网","labels":["corporation","rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592922274?lang=zh_cn&edition=full","pubTime":"2025-12-18 14:27","pubTimestamp":1766039221,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通将Recursion Pharmaceuticals的评级由“中性”上调至“增持”，理由是该公司核心资产REC - 4881具备成为“重磅炸弹”级产品的销售潜力。此外，该行还把Recursion的目标价从10美元提升至11美元。格罗弗写道：“这些临床结果及与制药企业的合作，进一步验证了Recursion的AI驱动研发管线，迄今已带来超过5亿美元的里程碑付款。”截至周三收盘，Recursion收涨11.43%，报4.68美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,rating","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4611","BK4139","BK4609","RXRX","BK4539","BK4548"],"gpt_icon":1},{"id":"1152493085","title":"Recursion Pharmaceuticals股价上涨6.1%，因其实验性疗法在稀有疾病试验中减少了息肉生长","url":"https://stock-news.laohu8.com/highlight/detail?id=1152493085","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152493085?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:34","pubTimestamp":1765204493,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals股价上涨6.1%，因其实验性疗法在稀有疾病试验中减少了息肉生长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4611","BK4139","BK4548","BK4609"],"gpt_icon":0},{"id":"1162082872","title":"Recursion：扩大年龄范围至18岁及以上，并进一步优化Rec-4881的给药计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1162082872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162082872?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197057,"startTime":"0","endTime":"0","summary":"Recursion：扩大年龄范围至18岁及以上，并进一步优化Rec-4881的给药计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4548","BK4539","BK4611","BK4139","BK4609"],"gpt_icon":0},{"id":"1114175506","title":"Recursion：可评估患者中82%在Rec-4881 Tupelo试验第25周维持了减少，基线中位下降53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114175506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114175506?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197048,"startTime":"0","endTime":"0","summary":"Recursion：可评估患者中82%在Rec-4881 Tupelo试验第25周维持了减少，基线中位下降53%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4548","BK4139","BK4539","RXRX","BK4611"],"gpt_icon":0},{"id":"1149287496","title":"Recursion: Rec-4881 Tupelo 1B/2期试验结果显示家族性腺瘤性息肉病的息肉负担在25周内迅速且持久减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1149287496","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149287496?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:30","pubTimestamp":1765197037,"startTime":"0","endTime":"0","summary":"Recursion: Rec-4881 Tupelo 1B/2期试验结果显示家族性腺瘤性息肉病的息肉负担在25周内迅速且持久减少","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","RXRX","BK4609","BK4539","BK4611"],"gpt_icon":0},{"id":"1196674557","title":"Recursion Pharmaceuticals, Inc.宣布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验数据发布的网络研讨会","url":"https://stock-news.laohu8.com/highlight/detail?id=1196674557","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196674557?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:32","pubTimestamp":1764595958,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.宣布将于2025年12月8日举行网络研讨会，以发布关于Rec-4881在家族性腺瘤性息肉病的Tupelo 1B/2期临床试验的最新数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4609","BK4548","BK4611","RXRX"],"gpt_icon":0},{"id":"1161522573","title":"Recursion Pharmaceuticals 提交最多 710 万股 A 类普通股的公开发行申请 - SEC 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1161522573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161522573?lang=zh_cn&edition=full","pubTime":"2025-11-26 21:14","pubTimestamp":1764162856,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals 提交最多 710 万股 A 类普通股的公开发行申请 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4539","BK4548","BK4139","RXRX","BK4611"],"gpt_icon":0},{"id":"1137771451","title":"Recursion Pharmaceuticals第三季度营收498.3万美元，低于IBES预期的1700万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137771451","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137771451?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:40","pubTimestamp":1763570451,"startTime":"0","endTime":"0","summary":"11月5日消息——Recursion Pharmaceuticals第三季度的税前利润为-1.6225亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4609","BK4548","BK4539","BK4139","BK4611"],"gpt_icon":0},{"id":"1137595080","title":"英伟达概念股普跌，纳微半导体大跌8%，APLD跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137595080","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137595080?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:54","pubTimestamp":1761054890,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals跌超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/f92e0f6db243fa4c651bd54e727021b0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f92e0f6db243fa4c651bd54e727021b0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"15ee133e7201107be6cfd6e50c244292","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWV","NVTS","APLD","NBIS","RXRX"],"gpt_icon":0},{"id":"2573927472","title":"美股部分AI医疗概念股走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573927472?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936446,"startTime":"0","endTime":"0","summary":"格隆汇10月8日｜Recursion Pharmaceuticals涨超8%，CRISPR Therapeutics涨近7%，Tempus Al涨超3%，Hims & Hers Health涨超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4611","BK4556","BK4548","BK4139","BK4196","HIMS","RXRX","BK4588","LU1861558580.USD","BK4609","BK4585","CRSP","LU1861559042.SGD"],"gpt_icon":0},{"id":"2564386228","title":"美股异动 | 英伟达持仓股普跌 “亲儿子”CoreWeave(CRWV.US)跌超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564386228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564386228?lang=zh_cn&edition=full","pubTime":"2025-09-02 23:22","pubTimestamp":1756826577,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d219511f954aa127cc5019686dd7346","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["2NVD.UK","ARM","NVDL","SG9999014559.SGD","NVD","3NVD.UK","LU2108987350.USD","NVD2.UK","LU0889565833.HKD","NVD3.UK","LU2471134796.USD","IE00B19Z8X17.USD","NVDX","LU0823431647.USD","LU1035775433.USD","LU1674673428.USD","RXRX","SNVD.UK","SGXZ51526630.SGD","BK4533","LU0950373646.USD","IE00B19Z9505.USD","BK4529","NVDU","LU1934455863.HKD","LU0342679015.USD","LU1868836591.USD","LU2931357623.SGD","LU2361045086.USD","LU2361044865.SGD","NBIS","LU1852331112.SGD","LU2237957811.SGD","NVDD","NVIW.SI","LU2860962120.EUR","NVDS.UK","APLD","LU1064131342.USD","LU0823421416.USD","LU0444971666.USD","LU0170899867.USD","NVDA","LU1992135399.USD","NVDS","CRWV","IE00BJTD4N35.SGD","LU1923622614.USD","NVDY","LU2065170008.USD"],"gpt_icon":0},{"id":"2560115337","title":"美股异动 | 英伟达持仓概念股走低 CoreWeave(CRWV.US)跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560115337","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560115337?lang=zh_cn&edition=full","pubTime":"2025-08-19 23:59","pubTimestamp":1755619189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BN29S564.USD","LU0061474960.USD","LU0957791311.USD","IE00BQXX3D17.EUR","BK4532","3NVD.UK","LU2471134523.USD","SGXZ51526630.SGD","NVDX","LU1037948897.HKD","CRWV","LU1974910355.USD","NVD2.UK","LU0308772762.SGD","HK0000320223.HKD","LU0082616367.USD","NVDA","LU1496350502.SGD","SNVD.UK","NVDL","NVIW.SI","NBIS","NVD","IE00BWXC8680.SGD","LU0265550359.USD","LU1720051108.HKD","RXRX","LU1935043536.SGD","LU0211328371.USD","LU2168563687.JPY","NVDS","LU1633808545.USD","LU1280957306.USD","LU1699723380.USD","NVDU","HK0000306701.USD","LU0979878070.USD","BK4554","LU2168564495.EUR","LU2430703178.SGD","LU2473716301.USD","APLD","NVD3.UK","NVDY","2NVD.UK","LU2083900584.USD","LU2023250330.USD","NVDD","ARM","NVDS.UK"],"gpt_icon":0},{"id":"2558616397","title":"Recursion Pharmaceuticals, Inc.8月11日成交额为1.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558616397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558616397?lang=zh_cn&edition=full","pubTime":"2025-08-12 13:57","pubTimestamp":1754978240,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Recursion Pharmaceuticals, Inc.成交额为1.01亿美元，成交额较昨日增加53.29%，当日成交量为1867.26万股。Recursion Pharmaceuticals, Inc.于2025年8月11日跌1.31%，报5.29美元，该股过去5个交易日跌8.79%，年初至今跌21.75%，过去60日涨22.74%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|1.01亿|53.29%|1867.26万|#|2025-08-08|6556.78万|-16.78%|1205.80万|#|2025-08-07|7878.75万|-19.27%|1434.20万|#|2025-08-06|9759.56万|-51.71%|1809.23万|#|2025-08-05|2.02亿|86.15%|3571.36万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812135726a483623e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812135726a483623e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4609","BK4539","BK4139","RXRX","BK4611","BK4548"],"gpt_icon":1},{"id":"2558684891","title":"Recursion Pharmaceuticals, Inc.2025财年第二财季实现净利润-1.72亿美元，同比减少76.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684891","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558684891?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:00","pubTimestamp":1754841656,"startTime":"0","endTime":"0","summary":"8月11日，Recursion Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第二财季净利润为-1.72亿美元，同比减少76.34%；其中营业收入为19.22百万美元，同比增加33.29%，每股基本收益为-0.41美元。从资产负债表来看，Recursion Pharmaceuticals, Inc.总负债3.83亿美元，其中短期债务20.48百万美元，资产负债比为3.40，流动比率为3.58。机构评级：截至2025年8月11日，当前有6家机构对Recursion Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.50美元，其中最低目标价为3.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000203a4805675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000203a4805675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX"],"gpt_icon":1},{"id":"2558506172","title":"Recursion Pharmaceuticals, Inc.8月8日成交额为6556.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558506172","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558506172?lang=zh_cn&edition=full","pubTime":"2025-08-09 13:56","pubTimestamp":1754719019,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Recursion Pharmaceuticals, Inc.成交额为6556.78万美元，成交额较昨日减少16.78%，当日成交量为1205.80万股。Recursion Pharmaceuticals, Inc.于2025年8月8日跌0.92%，报5.36美元，该股过去5个交易日跌5.63%，年初至今跌20.71%，过去60日涨18.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|6556.78万|-16.78%|1205.80万|#|2025-08-07|7878.75万|-19.27%|1434.20万|#|2025-08-06|9759.56万|-51.71%|1809.23万|#|2025-08-05|2.02亿|86.15%|3571.36万|#|2025-08-04|1.09亿|5.67%|1870.42万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809135704a6dc2930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809135704a6dc2930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4539","BK4548","BK4609","BK4139","RXRX"],"gpt_icon":1},{"id":"2557051090","title":"Recursion Pharmaceuticals, Inc.8月7日成交额为7878.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557051090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557051090?lang=zh_cn&edition=full","pubTime":"2025-08-08 13:54","pubTimestamp":1754632442,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Recursion Pharmaceuticals, Inc.成交额为7878.75万美元，成交额较昨日减少19.27%，当日成交量为1434.20万股。Recursion Pharmaceuticals, Inc.于2025年8月7日跌1.28%，报5.41美元，该股过去5个交易日跌9.08%，年初至今跌19.97%，过去60日涨16.59%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|7878.75万|-19.27%|1434.20万|#|2025-08-06|9759.56万|-51.71%|1809.23万|#|2025-08-05|2.02亿|86.15%|3571.36万|#|2025-08-04|1.09亿|5.67%|1870.42万|#|2025-08-01|1.03亿|-21.15%|1803.24万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808135408a47c8107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808135408a47c8107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4548","RXRX","BK4139","BK4609","BK4611"],"gpt_icon":1},{"id":"2557536600","title":"Recursion Pharmaceuticals, Inc.8月6日成交额为9759.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557536600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557536600?lang=zh_cn&edition=full","pubTime":"2025-08-07 13:48","pubTimestamp":1754545701,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Recursion Pharmaceuticals, Inc.成交额为9759.56万美元，成交额较昨日减少51.71%，当日成交量为1809.23万股。Recursion Pharmaceuticals, Inc.于2025年8月6日跌0.9%，报5.48美元，该股过去5个交易日跌5.68%，年初至今跌18.93%，过去60日涨26.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|9759.56万|-51.71%|1809.23万|#|2025-08-05|2.02亿|86.15%|3571.36万|#|2025-08-04|1.09亿|5.67%|1870.42万|#|2025-08-01|1.03亿|-21.15%|1803.24万|#|2025-07-31|1.30亿|6.44%|2199.56万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807134826a6d80989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807134826a6d80989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","BK4611","BK4609","RXRX","BK4539"],"gpt_icon":1},{"id":"2557323886","title":"Recursion Pharmaceuticals, Inc.8月5日成交额为2.02亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557323886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557323886?lang=zh_cn&edition=full","pubTime":"2025-08-06 13:41","pubTimestamp":1754458913,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Recursion Pharmaceuticals, Inc.成交额为2.02亿美元，成交额较昨日增加86.15%，当日成交量为3571.36万股。Recursion Pharmaceuticals, Inc.于2025年8月5日跌4.66%，报5.53美元，该股过去5个交易日跌7.06%，年初至今跌18.2%，过去60日涨25.97%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|2.02亿|86.15%|3571.36万|#|2025-08-04|1.09亿|5.67%|1870.42万|#|2025-08-01|1.03亿|-21.15%|1803.24万|#|2025-07-31|1.30亿|6.44%|2199.56万|#|2025-07-30|1.22亿|-14.71%|2049.73万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806134155a6d5dc9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806134155a6d5dc9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4611","BK4139","BK4609","BK4539","RXRX"],"gpt_icon":1},{"id":"1100182703","title":"异动解读 | Recursion Pharmaceuticals盘中大跌5%，季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1100182703","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100182703?lang=zh_cn&edition=full","pubTime":"2025-08-05 23:51","pubTimestamp":1754409106,"startTime":"0","endTime":"0","summary":"生物技术公司Recursion Pharmaceuticals, Inc.今日盘中股价大跌5%，主要原因是公司公布的季度业绩未达市场预期。根据公司最新发布的财报显示，截至6月30日的季度，Recursion Pharmaceuticals调整后每股亏损41美分，低于分析师平均预期的每股亏损35美分。该季度公司净亏损高达1.719亿美元。Recursion Pharmaceuticals是一家临床阶段的生物技术公司，致力于通过整合生物学、化学、自动化、数据科学和工程学的技术创新来解码生物学，以改善患者生活并推动药物发现产业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03917963db0c3a205e2bbf6933ec0db1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXRX"],"gpt_icon":1},{"id":"2557505353","title":"Recursion Pharmaceuticals, Inc.8月4日成交额为1.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557505353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557505353?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:41","pubTimestamp":1754372492,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Recursion Pharmaceuticals, Inc.成交额为1.09亿美元，成交额较昨日增加5.67%，当日成交量为1870.42万股。Recursion Pharmaceuticals, Inc.于2025年8月4日涨2.11%，报5.8美元，该股过去5个交易日跌8.08%，年初至今跌14.2%，过去60日涨38.42%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|1.09亿|5.67%|1870.42万|#|2025-08-01|1.03亿|-21.15%|1803.24万|#|2025-07-31|1.30亿|6.44%|2199.56万|#|2025-07-30|1.22亿|-14.71%|2049.73万|#|2025-07-29|1.44亿|-10.04%|2388.00万|Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805134143a475dd92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805134143a475dd92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","RXRX","BK4611","BK4609","BK4139","BK4539"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":-0.0162},{"period":"1month","weight":0.0571},{"period":"3month","weight":-0.1324},{"period":"6month","weight":-0.1531},{"period":"1year","weight":-0.3005},{"period":"ytd","weight":-0.3698}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 该公司是一家领先的临床阶段TechBio公司，将生物解码以将药物发现产业化。公司使命的核心是递归操作系统（OS），这是一个跨多种技术构建的平台，使公司能够在超过50 PB的专有数据中绘制和导航数万亿个以生物、化学和患者为中心的关系。该公司将物理和数字组件的这种集成框定为迭代循环，其中规模化的“湿实验室”生物学、化学和以患者为中心的实验数据由“干实验室”计算工具组织，以便识别、验证和翻译治疗见解。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.050758},{"month":2,"riseRate":0.5,"avgChangeRate":0.092727},{"month":3,"riseRate":0,"avgChangeRate":-0.270652},{"month":4,"riseRate":0.25,"avgChangeRate":-0.144468},{"month":5,"riseRate":0.4,"avgChangeRate":0.084296},{"month":6,"riseRate":0.6,"avgChangeRate":0.136566},{"month":7,"riseRate":0.8,"avgChangeRate":0.206054},{"month":8,"riseRate":0.2,"avgChangeRate":-0.126569},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050486},{"month":10,"riseRate":0.2,"avgChangeRate":-0.079168},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":0.006358}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}